Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 1144-1146

  Cota, Jason M ^a,b   Grabinski, Jodi L ^a,b   Talbert, Robert L ^a,b   Burgess, David S ^a,b   Rogers, P David ^c   Edlind, Thomas D ^d   Wiederhold, Nathan P ^a,b,e  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CHITIN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANDIDA GLABRATA; DRUG EFFECT; FUNGAL CELL; FUNGAL GENE; FUNGAL METABOLISM; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENOME; GENOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SLT2 GENE; UPREGULATION;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CHITIN; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FUNGAL PROTEINS; MICROBIAL SENSITIVITY TESTS; MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 40549084007     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01542-07     Document Type: Article

References (25)

1. Agarwal, A. K., P. D. Rogers, S. R. Baerson, M. R. Jacob, K. S. Barker, J. D. Cleary, L. A. Walker, D. G. Nagle, and A. M. Clark. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278:34998-35015.
2. Barchiesi, F., E. Spreghini, A. W. Fothergill, D. Arzeni, G. Greganti, D. Giannini, M. G. Rinaldi, and G. Scalise. 2005. Caspofungin in combination with amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:2546-2549.
3. Barchiesi, F., E. Spreghini, S. Tomassetti, D. Arzeni, D. Giannini, and G. Scalise. 2005. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:4989-4992.
4. Chamilos, G., R. E. Lewis, N. Albert, and D. P. Kontoyiannis. 2007. Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob. Agents Chemother. 51:2257-2259.
5. Clancy, C. J., H. Huang, S. Cheng, H. Derendorf, and M. H. Nguyen. 2006. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob. Agents Chemother. 50:2569-2572.
6. Cota, J., M. Carden, J. R. Graybill, L. K. Najvar, D. S. Burgess, and N. P. Wiederhold. 2006. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob. Agents Chemother. 50:3926-3928.
7. Edlind, T. D., K. W. Henry, J. P. Vermitsky, M. P. Edlind, S. Raj, and S. K. Katiyar. 2005. Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast. Curr. Genet. 48:117-125.
8. Heinisch, J. J., A. Lorberg, H. P. Schmitz, and J. J. Jacoby. 1999. The protein kinase C-mediated MAP kinase pathway involved in the maintenance of cellular integrity in Saccharomyces cerevisiae. Mol. Microbiol. 32:671-680.
9. Klepser, M. E., E. J. Ernst, R. E. Lewis, M. E. Ernst, and M. A. Pfaller. 1998. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42:1207-1212.
10. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
11. Markovich, S., A. Yekutiel, I. Shalit, Y. Shadkchan, and N. Osherov. 2004. Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48:3871-3876.
12. Mazur, P., N. Morin, W. Baginsky, M. el-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15:5671-5681.
13. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, P. J. Donnelly, and P. E. Verweij. 2001. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis[2-methoxy-4-nitro-5- [(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:4256-4263.
14. Munro, C. A., S. Selvaggini, I. de Bruijn, L. Walker, M. D. Lenardon, B. Gerssen, S. Milne, A. J. Brown, and N. A. Gow. 2007. The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol. Microbiol. 63:1399-1413.
15. Osherov, N., G. S. May, N. D. Albert, and D. P. Kontoyiannis. 2002. Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:2462-2469.
16. Pfaller, M., J. Riley, and T. Koerner. 1989. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 8:1067-1070.
17. Reinoso-Martin, C., C. Schuller, M. Schuetzer-Muehlbauer, and K. Kuchler. 2003. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot. Cell 2:1200-1210.
18. Ride, J. P., and R. B. Drysdale. 1972. A rapid method for the chemical estimation of filamentous fungi in plant tissue. Physiol. Plant Pathol. 2:7-15.
19. Shaw, J. A., P. C. Mol., B. Bowers, S. J. Silverman, M. H. Valdivieso, A. Duran, and E. Cabib. 1991. The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle. J. Cell Biol. 114:111-123.
20. Stevens, D. A., M. Espiritu, and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48:3407-3411.
21. Stevens, D. A., M. Ichinomiya, Y. Koshi, and H. Horiuchi. 2006. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother. 50:3160-3161.
22. Wiederhold, N. P., D. P. Kontoyiannis, R. A. Prince, and R. E. Lewis. 2005. Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob. Agents Chemother. 49:5146-5148.
23. Wiederhold, N. P., L. K. Najvar, R. Bocanegra, D. Molina, M. Olivo, and J. R. Graybill. 2007. In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera. Antimicrob. Agents Chemother. 51:1616-1620.
24. Zhao, C., U. S. Jung, P. Garrett-Engele, T. Roe, M. S. Cyert, and D. E. Levin. 1998. Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol. Cell. Biol. 18:1013-1022.
25. Ziman, M., J. S. Chuang, and R. W. Schekman. 1996. Chs1p and Chs3p, two proteins involved in chitin synthesis, populate a compartment of the Saccharomyces cerevisiae endocytic pathway. Mol. Biol. Cell 7:1909-1919.